Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.

Kenneth B Gordon; Richard G Langley; Craig Leonardi; Darryl Toth; M Alan Menter; Sewon Kang; Michael Heffernan; Bruce Miller; Regina Hamlin; Liberata Lim

doi:10.1016/j.jaad.2006.05.027

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.

Identifier:nobleid.org/w1/20260515/23AFD8AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/23AFD8AF.svg?ark=w1%2F20260515%2F23AFD8AF)](https://nobleid.org/work/w1/20260515/23AFD8AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.

Identifier:nobleid.org/w1/20260515/23AFD8AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/23AFD8AF.svg?ark=w1%2F20260515%2F23AFD8AF)](https://nobleid.org/work/w1/20260515/23AFD8AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work